{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T06:16:44Z","timestamp":1782022604292,"version":"3.54.5"},"reference-count":117,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006380","name":"Universit\u00e4t f\u00fcr Bodenkultur Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P36105-B"],"award-info":[{"award-number":["P36105-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["WO2020169577A1"],"award-info":[{"award-number":["WO2020169577A1"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.drudis.2025.104383","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:25:33Z","timestamp":1747826733000},"page":"104383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of histamine receptor antagonists in the treatment of histamine-driven clinical symptoms: do we have a histamine or, better, an anti-histamine problem?"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-0797","authenticated-orcid":false,"given":"Thomas","family":"Boehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104383_b0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01973821","article-title":"Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions?","volume":"14","author":"Hesterberg","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.drudis.2025.104383_b0010","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaci.2021.03.043","article-title":"Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"148","author":"Boehm","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0015","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(82)90394-X","article-title":"Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice","volume":"31","author":"Endo","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-2478(92)90086-4","article-title":"GM-CSF and G-CSF stimulate the synthesis of histamine and putrescine in the hematopoietic organs in vivo","volume":"33","author":"Endo","year":"1992","journal-title":"Immunol Lett"},{"key":"10.1016\/j.drudis.2025.104383_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s000110050438","article-title":"Regulation of histamine synthesis in mouse CD4+ and CD8+ T lymphocytes","volume":"48","author":"Kubo","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2025.104383_b0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00011-023-01699-y","article-title":"IL-33 induces histidine decarboxylase, especially in c-kit+ cells and mast cells, and roles of histamine include negative regulation of IL-33-induced eosinophilia","volume":"72","author":"Bando","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2025.104383_b0035","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"Brightling","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104383_b0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-6749(83)90096-9","article-title":"Histologic studies of chronic idiopathic urticaria","volume":"71","author":"Natbony","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/jid.1960.38","article-title":"Skin histamine levels in chronic atopic dermatitis","volume":"34","author":"Johnson","year":"1960","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2025.104383_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.drudis.2025.104383_b0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2025.104383_b0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2010.04.009","article-title":"Involvement of mast cells in eosinophilic esophagitis","volume":"126","author":"Abonia","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02899101","article-title":"Mast cells in ulcerative colitis. Quantitative and ultrastructural studies","volume":"57","author":"Balazs","year":"1989","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.drudis.2025.104383_b0070","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/art.1780270803","article-title":"Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases","volume":"27","author":"Godfrey","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.drudis.2025.104383_b0075","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/art.1780290803","article-title":"Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides","volume":"29","author":"Malone","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.drudis.2025.104383_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2025.104383_b0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1567-5769(02)00235-7","article-title":"Effects of histamine on Th1\/Th2 cytokine balance","volume":"3","author":"Packard","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0090","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaip.2016.11.037","article-title":"Chronic idiopathic urticaria: systemic complaints and their relationship with disease and immune measures","volume":"5","author":"Doong","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.drudis.2025.104383_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2222.1983.tb02568.x","article-title":"Measurement of plasma histamine in asthma","volume":"13","author":"Ind","year":"1983","journal-title":"Clin Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2022.04.023","article-title":"Massive release of TH2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"150","author":"Boehm","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0091-6749(78)90113-6","article-title":"Assessment of tissue fluid histamine levels in patients with urticaria","volume":"61","author":"Kaplan","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0110","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","article-title":"Histamine and histamine intolerance","volume":"85","author":"Maintz","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.drudis.2025.104383_b0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(82)80005-5","article-title":"Effects of infused histamine: correlation of plasma histamine levels and symptoms","volume":"69","author":"Kaliner","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF01965099","article-title":"Concentration effect relationships of infused histamine in normal volunteers","volume":"12","author":"Ind","year":"1982","journal-title":"Agents Actions"},{"key":"10.1016\/j.drudis.2025.104383_b0125","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/BF01716957","article-title":"Effects of histamine on the circulatory system","volume":"60","author":"Owen","year":"1982","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.drudis.2025.104383_b0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0091-6749(91)90008-C","article-title":"Catecholamine responses to histamine infusion in man","volume":"87","author":"Schellenberg","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/009127002401102713","article-title":"Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2","volume":"42","author":"Middleton","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0002-8703(81)90030-2","article-title":"Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris","volume":"102","author":"Ginsburg","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.drudis.2025.104383_b0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00005344-198307000-00004","article-title":"Cardiovascular effects of histamine infusion in man","volume":"5","author":"Vigorito","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0091-6749(06)80017-5","article-title":"Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation","volume":"90","author":"Van der Linden","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2015.00065","article-title":"The histamine H4 receptor: from orphan to the clinic","volume":"6","author":"Thurmond","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000542-198109000-00028","article-title":"Hemodynamics, plasma histamine, and catecholamine concentrations during an anaphylactoid reaction to morphine","volume":"55","author":"Fahmy","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drudis.2025.104383_b0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1213\/00000539-199809000-00036","article-title":"Oral antihistamines reduce the side effects from rapid vancomycin infusion","volume":"87","author":"Renz","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.drudis.2025.104383_b0170","first-page":"e5","article-title":"Brief communication: MRGPRX2, atopic dermatitis and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch (Phila)"},{"key":"10.1016\/j.drudis.2025.104383_b0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104383_b0180","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/69.5.508","article-title":"In vitro displacement of vasoactive mediators from plasma proteins: a possible mechanism for pseudo-allergic reactions to neuromuscular blocking drugs","volume":"69","author":"Williams","year":"1992","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.drudis.2025.104383_b0185","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00011-023-01783-3","article-title":"Recombinant human diamine oxidase prevents hemodynamic effects of continuous histamine infusion in guinea pigs","volume":"72","author":"Weiss-Tessbach","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2025.104383_b0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1113\/jphysiol.1959.sp006254","article-title":"The distribution and fate of radioactive histamine in the rat","volume":"147","author":"Halpern","year":"1959","journal-title":"J Physiol"},{"key":"10.1016\/j.drudis.2025.104383_b0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01980899","article-title":"Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects","volume":"32","author":"Pollock","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.drudis.2025.104383_b0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1148\/radiology.209.1.9769830","article-title":"Mechanisms of severe, immediate reactions to iodinated contrast material","volume":"209","author":"Laroche","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.drudis.2025.104383_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ALN.0000000000000276","article-title":"Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia","volume":"121","author":"Laroche","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drudis.2025.104383_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eclinm.2018.07.002","article-title":"Immediate hypersensitivity to contrast agents: the French 5-year CIRTACI study","volume":"1","author":"Clement","year":"2018","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.drudis.2025.104383_b0215","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/bja\/65.6.833","article-title":"Massive histamine release in a patient with systemic mastocytosis","volume":"65","author":"Desborough","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.drudis.2025.104383_b0220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/BF01716946","article-title":"Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject","volume":"60","author":"Lorenz","year":"1982","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.drudis.2025.104383_b0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/all.13663","article-title":"Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients","volume":"74","author":"Boehm","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local immune response to food antigens drives meal-induced abdominal pain","volume":"590","author":"Aguilera-Lizarraga","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104383_b0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1523-1747.ep12514352","article-title":"In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling","volume":"67","author":"Kaplan","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.drudis.2025.104383_b0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0091-6749(86)90033-3","article-title":"Prostaglandin D2 and histamine release in cold urticaria","volume":"78","author":"Heavey","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0091-6749(83)90068-4","article-title":"Antigen-induced local mediator release and cellular inflammatory responses in atopic subjects","volume":"71","author":"Bedard","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13601-017-0141-3","article-title":"Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria","volume":"7","author":"Van den Elzen","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0260","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0091-6749(86)90377-5","article-title":"Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine","volume":"77","author":"Cohen","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0265","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0091-6749(92)90297-F","article-title":"Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission","volume":"89","author":"Jacques","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104383_b0275","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2222.1993.tb00293.x","article-title":"Abnormalities in histamine pharmacodynamics in chronic urticaria","volume":"23","author":"Kanny","year":"1993","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0280","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2222.1983.tb02636.x","article-title":"Plasma histamine concentrations in atopic eczema","volume":"13","author":"Ring","year":"1983","journal-title":"Clin Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0285","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM198408093110605","article-title":"Increased plasma histamine concentrations after food challenges in children with atopic dermatitis","volume":"311","author":"Sampson","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104383_b0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ijd.13353","article-title":"Omalizumab for atopic dermatitis: case series and a systematic review of the literature","volume":"56","author":"Holm","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.drudis.2025.104383_b0295","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature12655","article-title":"Staphylococcus \u03b4-toxin induces allergic skin disease by activating mast cells","volume":"503","author":"Nakamura","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104383_b0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/jcm4040741","article-title":"Histamine and skin barrier: are histamine antagonists useful for the prevention or treatment of atopic dermatitis?","volume":"4","author":"De Benedetto","year":"2015","journal-title":"J Clin Med"},{"key":"10.1016\/j.drudis.2025.104383_b0305","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/ACI.0000000000000477","article-title":"Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017\/2018","volume":"18","author":"Werfel","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0310","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bph.14550","article-title":"The role of the histamine H4 receptor in atopic dermatitis and psoriasis","volume":"177","author":"Schaper-Gerhardt","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0315","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","article-title":"Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review","volume":"125","author":"Gonzalez-P\u00e9rez","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0320","doi-asserted-by":"crossref","first-page":"A2607","DOI":"10.1016\/j.chest.2022.08.2131","article-title":"Mortality outcomes and 30-day readmissions in hospitalized asthma patients with anaphylaxis","volume":"162","author":"Khalil","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.drudis.2025.104383_b0325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0091-6749(77)90111-7","article-title":"The relationship of plasma histamine to the activity of bronchial asthma","volume":"60","author":"Simon","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0330","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/cs0620661","article-title":"Plasma histamine and catecholamines in stable asthmatic subjects","volume":"62","author":"Barnes","year":"1982","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.drudis.2025.104383_b0335","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0091-6749(91)90158-K","article-title":"Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway","volume":"88","author":"Broide","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0340","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI112937","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness","volume":"79","author":"Casale","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104383_b0345","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0091-6749(89)90293-5","article-title":"The relationship between plasma histamine concentrations and bronchial obstruction to antigen challenge in allergic rhinitis","volume":"84","author":"Busse","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0091-6749(80)90009-3","article-title":"Comparison of plasma histamine and cyclic nucleotides after antigen and methacholine inhalation in man","volume":"66","author":"Atkins","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/ajrccm\/144.1.83","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction","volume":"144","author":"Jarjour","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.drudis.2025.104383_b0360","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI114051","article-title":"Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis","volume":"83","author":"Schwartz","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104383_b0365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104383_b0370","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1172\/JCI117581","article-title":"A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects","volume":"94","author":"Calhoun","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104383_b0375","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI101764","article-title":"The action of histamine on the respiratory tract in normal and asthmatic subjects","volume":"25","author":"Curry","year":"1946","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104383_b0380","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/S0091-6749(96)80116-3","article-title":"Clinical comparison of histamine H1-receptor antagonist drugs","volume":"98","author":"Du Buske","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0385","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case\u2013control cohort study of patients' perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104383_b0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.drudis.2025.104383_b0395","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/all.12842","article-title":"Development and validation of the mastocytosis quality of life questionnaire: MC-QoL","volume":"71","author":"Siebenhaar","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0400","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/all.13425","article-title":"Development and validation of the mastocytosis activity score","volume":"73","author":"Siebenhaar","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01852292","article-title":"Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease","volume":"180","author":"Baumann","year":"1982","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.drudis.2025.104383_b0410","first-page":"177","article-title":"Cimetidine induces coronary artery spasm in patients with vasospastic angina","volume":"3","author":"Shimokawa","year":"1987","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.drudis.2025.104383_b0415","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00000542-198109000-00019","article-title":"The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study","volume":"55","author":"Philbin","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drudis.2025.104383_b0420","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1097\/00003246-199909000-00006","article-title":"Antihistamine prophylaxis permits rapid vancomycin infusion","volume":"27","author":"Renz","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.drudis.2025.104383_b0425","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0091-6749(97)70135-0","article-title":"Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial","volume":"100","author":"Brockow","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0430","series-title":"Clarinex (Desloratidine) Prescription Information","author":"FDA","year":"2002"},{"key":"10.1016\/j.drudis.2025.104383_b0435","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mai.2001.114239","article-title":"Desloratadine: a new, nonsedating, oral antihistamine","volume":"107","author":"Geha","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0440","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"Van Cauwenberge","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0445","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1346-8138.2001.tb00126.x","article-title":"Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment","volume":"28","author":"Fujii","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.drudis.2025.104383_b0450","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0455","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000446183","article-title":"Seasonal exacerbation of asthma Is frequently associated with recurrent episodes of acute urticaria","volume":"169","author":"Vadasz","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0460","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2125.1995.tb05727.x","article-title":"A double-blind, placebo-controlled study of the effect of the specific histamine H1-receptor antagonist, terfenadine, in chronic severe asthma","volume":"39","author":"Wood-Baker","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0465","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1067\/mai.2002.123644","article-title":"Exercise-induced asthma: is there still a case for histamine?","volume":"109","author":"Anderson","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0470","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1398-9995.1997.tb04812.x","article-title":"Antihistamines in the treatment of asthma","volume":"52","author":"Malick","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0475","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.anai.2018.08.001","article-title":"A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma","volume":"121","author":"Kollmeier","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0480","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jaci.2018.07.047","article-title":"Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis","volume":"143","author":"Werfel","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0485","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.drudis.2025.104383_b0490","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/WOX.0b013e3181b35322","article-title":"The role of antihistamines in the treatment of vasomotor rhinitis","volume":"2","author":"Lieberman","year":"2009","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.drudis.2025.104383_b0495","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1016\/j.bmc.2006.05.077","article-title":"Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5\u2013phenyl-1,2,3,4-tetrahydronaphthalenes","volume":"14","author":"Ghoneim","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2025.104383_b0500","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1939-1676.2003.tb02433.x","article-title":"Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors","volume":"17","author":"Ishiguro","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.drudis.2025.104383_b0505","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjp.0707318","article-title":"Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig","volume":"151","author":"Gupta","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2025.104383_b0510","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00126839-200607040-00002","article-title":"In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist","volume":"7","author":"Corcostegui","year":"2006","journal-title":"Drugs R D"},{"key":"10.1016\/j.drudis.2025.104383_b0515","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1034\/j.1398-9995.1999.00038.x","article-title":"Measurement of interstitial cetirizine concentrations in human skin: correlation of drug levels with inhibition of histamine-induced skin responses","volume":"54","author":"Petersen","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.drudis.2025.104383_b0520","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0091-6749(95)70183-4","article-title":"Quantitation of H1-receptor antagonists in skin and serum","volume":"95","author":"Simons","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0525","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1067\/mai.2001.113080","article-title":"Skin concentrations of H1-receptor antagonists","volume":"107","author":"Simons","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.drudis.2025.104383_b0530","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mai.2002.129123","article-title":"Clinical pharmacology of H1-antihistamines in the skin","volume":"110","author":"Simons","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.drudis.2025.104383_b0535","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1148\/radiology.162.1.3786753","article-title":"Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy","volume":"162","author":"van Sonnenberg","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.drudis.2025.104383_b0540","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1520\/JFS2002121","article-title":"Fatal diphenhydramine intoxication in infants","volume":"48","author":"Baker","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.drudis.2025.104383_b0545","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/15563650802116151","article-title":"Fatal diphenhydramine poisoning with increased vascular permeability including late pulmonary congestion refractory to percutaneous cardiovascular support","volume":"46","author":"Kamijo","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.drudis.2025.104383_b0550","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jbiotec.2016.04.002","article-title":"Characterization of recombinant human diamine oxidase (rhDAO) produced in Chinese Hamster Ovary (CHO) cells","volume":"227","author":"Gludovacz","year":"2016","journal-title":"J Biotechnol"},{"key":"10.1016\/j.drudis.2025.104383_b0555","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68542","article-title":"Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical","volume":"10","author":"Gludovacz","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2025.104383_b0560","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00011-022-01558-2","article-title":"Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine","volume":"71","author":"Karer","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2025.104383_b0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132367","article-title":"Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo","volume":"10","author":"Ashina","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104383_b0570","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1038\/ncomms7725","article-title":"RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock","volume":"6","author":"Mikelis","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104383_b0575","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/art.1780140503","article-title":"Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation","volume":"14","author":"Kushner","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.drudis.2025.104383_b0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0026-2862(74)90035-1","article-title":"Effects of histamine and some other substances on molecular selectivity of the capillary wall to plasma proteins and dextran","volume":"7","author":"Carter","year":"1974","journal-title":"Microvasc Res"},{"key":"10.1016\/j.drudis.2025.104383_b0585","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-2999(02)02049-6","article-title":"Biochemical characterization of desloratadine, a potent antagonist of the human histamine H receptor","volume":"449","author":"Anthes","year":"2002","journal-title":"Eur J Pharmacol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:43:48Z","timestamp":1778802228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1359644625000960"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104383","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of histamine receptor antagonists in the treatment of histamine-driven clinical symptoms: do we have a histamine or, better, an anti-histamine problem?","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104383"}}